Arecor Therapeutics plc (AIM:AREC)

Arecor Therapeutics Statistics

Total Valuation

AIM:AREC has a market cap or net worth of GBP 27.00 million. The enterprise value is 25.28 million.

Market Cap	27.00M
Enterprise Value	25.28M

Important Dates

The next estimated earnings date is Wednesday, December 24, 2025.

Earnings Date	Dec 24, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM:AREC has 37.76 million shares outstanding. The number of shares has increased by 20.83% in one year.

Current Share Class	37.76M
Shares Outstanding	37.76M
Shares Change (YoY)	+20.83%
Shares Change (QoQ)	+4.15%
Owned by Insiders (%)	12.13%
Owned by Institutions (%)	51.14%
Float	22.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.33
PB Ratio	9.45
P/TBV Ratio	9.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.12
EV / Sales	5.00
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.06

Financial Position

The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.06.

Current Ratio	2.05
Quick Ratio	2.00
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-308.06

Financial Efficiency

Return on equity (ROE) is -204.29% and return on invested capital (ROIC) is -82.64%.

Return on Equity (ROE)	-204.29%
Return on Assets (ROA)	-44.39%
Return on Invested Capital (ROIC)	-82.64%
Return on Capital Employed (ROCE)	-189.64%
Revenue Per Employee	115,023
Profits Per Employee	-184,182
Employee Count	44
Asset Turnover	0.65
Inventory Turnover	12.39

Taxes

Income Tax	-265,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.14% in the last 52 weeks. The beta is -0.28, so AIM:AREC's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	-7.14%
50-Day Moving Average	73.37
200-Day Moving Average	54.57
Relative Strength Index (RSI)	39.78
Average Volume (20 Days)	30,102

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:AREC had revenue of GBP 5.06 million and -8.10 million in losses. Loss per share was -0.22.

Revenue	5.06M
Gross Profit	1.60M
Operating Income	-5.55M
Pretax Income	-8.37M
Net Income	-8.10M
EBITDA	-5.35M
EBIT	-5.55M
Loss Per Share	-0.22

Balance Sheet

The company has 1.89 million in cash and 173,000 in debt, giving a net cash position of 1.71 million or 0.05 per share.

Cash & Cash Equivalents	1.89M
Total Debt	173,000
Net Cash	1.71M
Net Cash Per Share	0.05
Equity (Book Value)	2.86M
Book Value Per Share	0.08
Working Capital	2.45M

Cash Flow

In the last 12 months, operating cash flow was -6.12 million and capital expenditures -106,000, giving a free cash flow of -6.22 million.

Operating Cash Flow	-6.12M
Capital Expenditures	-106,000
Free Cash Flow	-6.22M
FCF Per Share	-0.16

Margins

Gross margin is 31.67%, with operating and profit margins of -109.56% and -160.13%.

Gross Margin	31.67%
Operating Margin	-109.56%
Pretax Margin	-165.36%
Profit Margin	-160.13%
EBITDA Margin	-105.65%
EBIT Margin	-109.56%
FCF Margin	n/a

Dividends & Yields

AIM:AREC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.83%
Shareholder Yield	-20.83%
Earnings Yield	-30.02%
FCF Yield	-23.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AIM:AREC has an Altman Z-Score of -8.54 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.54
Piotroski F-Score	3